In March 2025, the company announced new designs to get a direct-to-consumer providing of its Wegovy weight loss drug. The company recognized a different pharmacy, named NovoCare, which might cost shoppers $499 a month for access to the drug, less than half the cost of the drug as a result of other pharmaceutical distribution networks.[fifty three]